Holdings, Inc. (NYSE:QTWO – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the sixteen research firms that are covering the company, Marketbeat Ratings reports.
Highlights Topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for expected release by early February 2025ATH434-201 trial in early-stage MSA completed in November ...